Charan Insurance Valuation
Is CHARAN-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CHARAN-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CHARAN-R (THB23.9) is trading below our estimate of fair value (THB44.58)
Significantly Below Fair Value: CHARAN-R is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CHARAN-R?
Other financial metrics that can be useful for relative valuation.
What is CHARAN-R's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿286.80m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.8x |
Enterprise Value/EBITDA | 8.2x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does CHARAN-R's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 7x | ||
BUI Bangkok Union Insurance | 4.9x | n/a | ฿684.7m |
NKI Navakij Insurance | 8.5x | n/a | ฿1.0b |
TVH Thaivivat Holdings | 9x | n/a | ฿2.5b |
INSURE Indara Insurance | 5.6x | n/a | ฿1.1b |
CHARAN-R Charan Insurance | 10.6x | n/a | ฿286.8m |
Price-To-Earnings vs Peers: CHARAN-R is expensive based on its Price-To-Earnings Ratio (10.6x) compared to the peer average (7x).
Price to Earnings Ratio vs Industry
How does CHARAN-R's PE Ratio compare vs other companies in the Asian Insurance Industry?
Price-To-Earnings vs Industry: CHARAN-R is good value based on its Price-To-Earnings Ratio (10.6x) compared to the Asian Insurance industry average (12x).
Price to Earnings Ratio vs Fair Ratio
What is CHARAN-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 10.6x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CHARAN-R's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.